Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ATRenew (RERE) Notes Payables (2020 - 2025)

ATRenew (RERE) has disclosed Notes Payables for 6 consecutive years, with $45.5 million as the latest value for Q4 2025.

  • Quarterly Notes Payables rose 45.32% to $45.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.5 million through Dec 2025, up 45.32% year-over-year, with the annual reading at $46.2 million for FY2025, 49.77% up from the prior year.
  • Notes Payables hit $45.5 million in Q4 2025 for ATRenew, up from $31.3 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $48.6 million in Q4 2023 to a low of $14.9 million in Q4 2021.
  • Historically, Notes Payables has averaged $31.5 million across 5 years, with a median of $31.3 million in 2024.
  • Biggest five-year swings in Notes Payables: plummeted 73.36% in 2021 and later surged 178.8% in 2023.
  • Year by year, Notes Payables stood at $14.9 million in 2021, then increased by 17.32% to $17.4 million in 2022, then surged by 178.8% to $48.6 million in 2023, then plummeted by 35.55% to $31.3 million in 2024, then surged by 45.32% to $45.5 million in 2025.
  • Business Quant data shows Notes Payables for RERE at $45.5 million in Q4 2025, $31.3 million in Q4 2024, and $48.6 million in Q4 2023.